Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
$1.81
-1.6%
$1.84
$0.87
$3.72
$88.65M1.66229,265 shs112,220 shs
IRIDEX Corporation stock logo
IRIX
IRIDEX
$1.28
-3.0%
$1.06
$0.78
$2.14
$21.49M0.62191,987 shs49,855 shs
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
$4.87
+5.6%
$4.25
$2.03
$5.81
$85.40M1139,389 shs123,359 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$5.58
-0.2%
$4.82
$4.01
$9.33
$91.76M1.34115,326 shs144,164 shs
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
0.00%-5.73%+10.70%+14.56%-43.26%
IRIDEX Corporation stock logo
IRIX
IRIDEX
0.00%-9.22%+39.74%+7.56%-36.32%
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
0.00%-1.81%+19.07%+37.18%-9.48%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
0.00%+1.27%+14.81%+28.87%-12.40%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
1.5988 of 5 stars
3.53.00.00.00.00.00.0
IRIDEX Corporation stock logo
IRIX
IRIDEX
0.4749 of 5 stars
0.04.00.00.00.61.70.0
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
0.3547 of 5 stars
0.02.00.00.01.50.80.6
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
1.9156 of 5 stars
3.53.00.00.02.70.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
3.00
Buy$11.00507.73% Upside
IRIDEX Corporation stock logo
IRIX
IRIDEX
0.00
N/AN/AN/A
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
0.00
N/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.00
Buy$11.67109.08% Upside

Current Analyst Ratings Breakdown

Latest IRIX, GUTS, SRTS, and NVNO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $10.00
(Data available from 8/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
$90K985.04N/AN/A$0.59 per share3.07
IRIDEX Corporation stock logo
IRIX
IRIDEX
$48.67M0.44N/AN/A$0.13 per share9.85
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
N/AN/AN/AN/A$2.40 per shareN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$41.81M2.19$0.43 per share12.92$3.41 per share1.64
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$68.69M-$1.85N/AN/AN/A-73,864.52%-228.66%-76.74%8/13/2025 (Estimated)
IRIDEX Corporation stock logo
IRIX
IRIDEX
-$8.91M-$0.43N/AN/A-14.61%-290.57%-22.86%8/12/2025 (Estimated)
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
-$21.82M-$1.18N/AN/AN/AN/A-54.13%-50.92%N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M$0.1055.8024.26N/A4.56%3.34%3.00%8/7/2025 (Estimated)

Latest IRIX, GUTS, SRTS, and NVNO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2025Q2 2025
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$0.37N/AN/AN/AN/AN/A
8/7/2025Q2 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.01N/AN/AN/A$9.30 millionN/A
7/31/2025Q2 2025
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
-$0.28-$0.33-$0.05-$0.33N/AN/A
5/15/2025Q1 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.04-$0.16-$0.20-$0.16$7.23 million$8.34 million
5/13/2025Q1 2025
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$0.49-$0.49N/A-$0.49N/AN/A
5/13/2025Q1 2025
IRIDEX Corporation stock logo
IRIX
IRIDEX
-$0.10-$0.10N/A-$0.10$12.10 million$11.90 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
N/AN/AN/AN/AN/A
IRIDEX Corporation stock logo
IRIX
IRIDEX
N/AN/AN/AN/AN/A
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
4.61
2.50
2.50
IRIDEX Corporation stock logo
IRIX
IRIDEX
4.28
1.95
1.27
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
N/A
23.77
23.77
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.06
5.74

Institutional Ownership

CompanyInstitutional Ownership
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
N/A
IRIDEX Corporation stock logo
IRIX
IRIDEX
20.10%
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
34.71%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%

Insider Ownership

CompanyInsider Ownership
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
N/A
IRIDEX Corporation stock logo
IRIX
IRIDEX
7.40%
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
16.00%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
10248.98 millionN/AN/A
IRIDEX Corporation stock logo
IRIX
IRIDEX
12016.79 million15.55 millionOptionable
enVVeno Medical Corporation stock logo
NVNO
enVVeno Medical
3017.54 million14.73 millionOptionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.44 million14.98 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Fractyl Health stock logo

Fractyl Health NASDAQ:GUTS

$1.81 -0.03 (-1.63%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$1.74 -0.07 (-3.87%)
As of 08/1/2025 07:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

IRIDEX stock logo

IRIDEX NASDAQ:IRIX

$1.28 -0.04 (-3.03%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$1.26 -0.02 (-1.56%)
As of 08/1/2025 04:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

enVVeno Medical stock logo

enVVeno Medical NASDAQ:NVNO

$4.87 +0.26 (+5.64%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$4.88 +0.00 (+0.10%)
As of 08/1/2025 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company's lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI). Deep venous CVI occurs when valves inside of the deep veins of the leg become damaged, resulting in insufficient blood being returned to the heart. The malfunctioning vein valves cause blood to flow backwards (reflux) and pool in the lower leg, increasing the pressure within the veins of the leg (venous hypertension). In the most severe cases, CVI can lead to venous ulcers (open skin sores) that become chronic and difficult to heal. The VenoValve is implanted in the femoral vein and works as a replacement venous valve, designed to reduce reflux and venous hypertension, and to restore proper directional blood flow back to the heart. With severe deep venous CVI impacting an estimated 2.4 million people in the U.S., who have no effective treatment options, the VenoValve has received Breakthrough Device Designation from the U.S. Food and Drug Administration, and is currently being evaluated in the SAVVE U.S. clinical trial.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$5.58 -0.01 (-0.18%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$5.38 -0.20 (-3.66%)
As of 08/1/2025 04:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.